Filing Details

Accession Number:
0001415889-24-002173
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-01 16:17:38
Reporting Period:
2024-01-30
Accepted Time:
2024-02-01 16:17:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578852 Elliott Mark Boulding C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Exec. Vp And Clo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-30 794 $27.25 71,189 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs.